One-Step
Animals
Antigens, Surface
/ analysis
Binding, Competitive
Borates
/ chemistry
Cell Line, Tumor
Fluorine Radioisotopes
/ chemistry
Glutamate Carboxypeptidase II
/ analysis
Humans
Male
Mice
Neoplasm Recurrence, Local
Neoplasm Transplantation
Positron Emission Tomography Computed Tomography
Prostate
/ diagnostic imaging
Prostatic Neoplasms
/ diagnostic imaging
Radiopharmaceuticals
/ pharmacology
Tissue Distribution
18F labeling
18F-trifluoroborate
PSMA
positron emission tomography
prostate cancer
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
26
06
2018
accepted:
13
01
2019
pubmed:
10
2
2019
medline:
14
4
2020
entrez:
10
2
2019
Statut:
ppublish
Résumé
After the identification of the high-affinity glutamate-ureido scaffold, the design of several potent
Identifiants
pubmed: 30737299
pii: jnumed.118.216598
doi: 10.2967/jnumed.118.216598
pmc: PMC6681697
doi:
Substances chimiques
Antigens, Surface
0
Borates
0
Fluorine Radioisotopes
0
Radiopharmaceuticals
0
FOLH1 protein, human
EC 3.4.17.21
Glutamate Carboxypeptidase II
EC 3.4.17.21
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1160-1166Subventions
Organisme : CIHR
ID : FDN-148465
Pays : Canada
Informations de copyright
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Cancer Res. 2001 Aug 1;61(15):5857-60
pubmed: 11479226
Prostate. 2003 Jun 1;55(4):308-16
pubmed: 12712410
J Am Chem Soc. 2004 Jul 28;126(29):8862-3
pubmed: 15264794
Int J Cancer. 2005 Sep 1;116(3):415-21
pubmed: 15800947
J Med Chem. 2008 Dec 25;51(24):7933-43
pubmed: 19053825
Bioorg Med Chem Lett. 2009 Jan 15;19(2):305-8
pubmed: 19091560
J Med Chem. 2009 Jan 22;52(2):347-57
pubmed: 19111054
Clin Cancer Res. 2011 Dec 15;17(24):7645-53
pubmed: 22042970
Appl Radiat Isot. 2012 Jun;70(6):922-30
pubmed: 22476015
J Nucl Med. 2014 Sep;55(9):1499-505
pubmed: 24970911
J Am Chem Soc. 2014 Jul 23;136(29):10450-9
pubmed: 24972336
Angew Chem Int Ed Engl. 2014 Oct 27;53(44):11876-80
pubmed: 25196467
Bioconjug Chem. 2014 Nov 19;25(11):1951-62
pubmed: 25265337
Eur J Nucl Med Mol Imaging. 2015 May;42(6):987-8
pubmed: 25573634
Mol Pharm. 2015 Mar 2;12(3):974-82
pubmed: 25629412
Bioorg Med Chem. 2015 Apr 1;23(7):1500-6
pubmed: 25757604
Mol Imaging Biol. 2015 Dec;17(6):777-85
pubmed: 25869080
J Nucl Med. 2015 Jun;56(6):914-20
pubmed: 25883127
Mol Imaging Biol. 2015 Aug;17(4):565-74
pubmed: 25896814
J Nucl Med. 2015 Jul;56(7):1003-1010
pubmed: 26069305
J Nucl Med. 2015 Aug;56(8):1169-76
pubmed: 26089548
J Nucl Med. 2015 Sep;56(9):1434-40
pubmed: 26205302
Q J Nucl Med Mol Imaging. 2015 Sep;59(3):241-68
pubmed: 26213140
Nat Protoc. 2015 Sep;10(9):1423-32
pubmed: 26313478
Theranostics. 2015 Oct 18;5(12):1388-401
pubmed: 26681984
Nat Rev Urol. 2016 Apr;13(4):226-35
pubmed: 26902337
Bioorg Med Chem Lett. 2016 Apr 1;26(7):1675-9
pubmed: 26922139
Acc Chem Res. 2016 Jul 19;49(7):1333-43
pubmed: 27054808
EJNMMI Res. 2016 Dec;6(1):40
pubmed: 27142881
J Nucl Med. 2016 Dec;57(12):1978-1984
pubmed: 27417647
J Nucl Med. 2017 Mar;58(3):425-431
pubmed: 27789722
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):678-688
pubmed: 27889802
J Nucl Med. 2018 May;59(5):789-794
pubmed: 29242404
Appl Radiat Isot. 2018 Mar;133:1-3
pubmed: 29272820
Nucl Med Biol. 2018 Jun;61:11-20
pubmed: 29597141
Mol Pharm. 2018 Jun 4;15(6):2116-2122
pubmed: 29714486
Mol Pharm. 2018 Aug 6;15(8):3502-3511
pubmed: 29920108
J Nucl Med. 2018 Jul 12;:null
pubmed: 30002112
J Nucl Med. 2019 Jun;60(6):817-823
pubmed: 30389823
J Nucl Med. 2019 Jul;60(7):910-916
pubmed: 30464040
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):749-53
pubmed: 8570628
Clin Cancer Res. 1997 Jan;3(1):81-5
pubmed: 9815541